Do statin users adhere to a healthy diet and lifestyle? The Australian Diabetes,Obesity and Lifestyle Study

Abstract

Background

Lifestyle and dietary advice typically precedes or accompanies the prescription of statin medications. However, evidence for adherence to this advice is sparse. The objective was to compare saturated fat intake, exercise, alcohol consumption and smoking between statin users and non-users in Australia.

Methods

Data were analysed for 4614 participants aged ≥37 years in the Australian Diabetes, Obesity and Lifestyle study in 2011–2012. Statin use, smoking status and physical activity were self-reported. Saturated fat and alcohol intake were measured via a food frequency questionnaire. Multinomial logistic regression was used to compute adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between statin use and the four lifestyle factors. All models were adjusted for age, sex, education, number of general practitioner visits, body mass index, hypertension, diabetes and prior cardiovascular diseases.

Results

In total 1108 (24%) participants used a statin. Statin users were 29% less likely to be within the highest quartile versus the lowest quartile of daily saturated fat intake compared to non-users (OR 0.71, 95% CI 0.54–0.94). There were no statistically significant associations between statin use and smoking, physical activity or alcohol consumption.

Conclusions

Smoking status, alcohol consumption and exercise level did not differ between users and non-users of statins. However, statin users were less likely to consume high levels of saturated fat than non-users. We found no evidence that people took statins to compensate for a poor diet or lifestyle.

Keywords

Smoking alcohol drinking exercise diet HMG-CoA reductase inhibitors epidemiology cohort study

Get full access to this article

View all access options for this article.

References

Sarikaya

Ferro

Arnold

. Stroke prevention – medical and lifestyle measures. Eur Neurol 2015; 73: 150–157.

Flock

Kris-Etherton

. Dietary guidelines for Americans 2010: implications for cardiovascular disease. Curr Atheroscler Rep 2011; 13: 499–507.

Sattelmair

Pertman

Ding

. Dose-response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 2011; 124: 789–795.

Ronksley

Brien

Turner

. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011; 342: d671–d671.

Piepoli

Hoes

Agewall

. The Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2016; 23: NP1–NP96.

Catapano A, Graham I, De Backer G, et al. The Task Force for the Management of Dyslipidaemias of the ESC and EAS. 2016 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. Epub ahead of print 27 August 2016. DOI: 10.1093/eurheartj/ehw272.

LaRosa

. Means and ends of statins and low-density lipoprotein cholesterol lowering. J Am Coll Cardiol 2007; 50: 419–420.

King

Mainous

III Carnemolla

. Adherence to healthy lifestyle habits in US adults, 1988–2006. Am J Med 2009; 122: 528–534.

Baigent

Keech

Kearney

. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–1278.

10.

LaRosa

Vupputuri

. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999; 282: 2340–2346.

11.

Gadzhanova

Roughead

Ilomäki

. Use of statins in an Australian elderly population. Int J Clin Cardiol 2014; 1: 1–4.

12.

National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification, www.nice.org.uk/guidance/cg181 (2016, accessed 6 October 2016).

13.

Pencina

Navar-Boggan

D’Agostino

. Application of new cholesterol guidelines to a population-based sample. N Engl J Med 2014; 370: 1422–1431.

14.

Mascitelli

Pezzetta

. Statins for primary prevention of coronary artery disease. Lancet 2007; 369: 1078–1079.

15.

Lytsy

Burell

Westerling

. Cardiovascular risk factor assessments and health behaviours in patients using statins compared to a non-treated population. Int J Behav Med 2012; 19: 134–142.

16.

Lee

Markwardt

Goeres

. Statins and physical activity in older men: the osteoporotic fractures in men study. JAMA Intern Med 2014; 174: 1263–1270.

17.

Sugiyama

Tsugawa

Tseng

. Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins? JAMA Intern Med 2014; 174: 1038–1045.

18.

Brewer

Cuite

Herrington

. Risk compensation and vaccination: can getting vaccinated cause people to engage in risky behaviors? Ann Behav Med 2007; 34: 95–99.

19.

Simic

Reiner

. Adverse effects of statins – myths and reality. Curr Pharm Des 2015; 21: 1220–1226.

20.

Dunstan

Zimmet

Welborn

. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) – methods and response rates. Diabetes Res Clin Pract 2002; 57: 119–129.

21.

World Health Organization. ATC/DDD index 2016, www.whocc.no/atc_ddd_index/ (2016, accessed 6 October 2016).

22.

Puaschitz

Strand

Norekval

. Dietary intake of saturated fat is not associated with risk of coronary events or mortality in patients with established coronary artery disease. J Nutr 2015; 145: 299–305.

23.

National Health and Medical Research Council. Australian guidelines to reduce health risks from drinking alcohol. Canberra: Australian Government, 2009.

24.

World Health Organization. BMI classification, http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (2015, accessed 6 October 2016).

25.

Whitworth

. World Health Organization and International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983–1992.

26.

World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, Geneva: World Health Organization, 1999.

27.

Rosenthal

Carroll-Scott

Earnshaw

. Targeting cessation: understanding barriers and motivations to quitting among urban adult daily tobacco smokers. Addict Behav 2013; 38: 1639–1642.

28.

Twyman

Bonevski

Paul

. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open 2014; 4: e006414–e006414.

29.

Prugger

Wellmann

Heidrich

. Readiness for smoking cessation in coronary heart disease patients across Europe: results from the Euroaspire III Survey. Eur J Prev Cardiol 2015; 22: 1212–1219.

30.

Prugger

Wellmann

Heidrich

. Passive smoking and smoking cessation among patients with coronary heart disease across Europe: results from the Euroaspire III Survey. Eur Heart J 2014; 35: 590–598.

31.

Helgason

Lund

. General practitioners’ perceived barriers to smoking cessation – results from four Nordic countries. Scand J Public Health 2002; 30: 141–147.

32.

Reiner

Sonicki

Tedeschi-Reiner

. Public perceptions of cardiovascular risk factors in croatia: the Percro survey. Prev Med 2010; 51: 494–496.

33.

Reiner

Sonicki

Tedeschi-Reiner

. Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the Percro-doc survey. Atherosclerosis 2010; 213: 598–603.

34.

Milionis

Rizos

Mikhailidis

. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology 2001; 52: 575–587.

35.

Thompson

Parker

. Statins, exercise, and exercise training. J Am Coll Cardiol 2013; 62: 715–716.

36.

Bruckert

Hayem

Dejager

. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients – the PRIMO study. Cardiovasc Drugs Ther 2005; 19: 403–414.

37.

Kaestner

Darden

Lakdawalla

. Are investments in disease prevention complements? The case of statins and health behaviors. J Health Econ 2014; 36: 151–163.

38.

Lipworth

Fazio

Kabagambe

. A prospective study of statin use and mortality among 67,385 blacks and whites in the southeastern United States. Clin Epidemiol 2014; 6: 15–25.

39.

Kaner

Heather

McAvoy

. Intervention for excessive alcohol consumption in primary health care: attitudes and practices of English general practitioners. Alcohol Alcohol 1999; 34: 559–566.

40.

Rimm

Williams

Fosher

. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523–1528.

41.

Movva

Figueredo

. Alcohol and the heart: to abstain or not to abstain? Int J Cardiol 2013; 164: 267–276.

42.

Bertholet

Daeppen

Wietlisbach

. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med 2005; 165: 986–995.